Dr. Engelhardt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000- Is this information wrong?
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
University of North Carolina HospitalsResidency, Internal Medicine, 2000 - 2003
Case Western Reserve University School of MedicineClass of 2000
Certifications & Licensure
TN State Medical License 2006 - 2024
AL State Medical License 2020 - 2020
NC State Medical License 2000 - 2008- American Board of Internal Medicine Hematology
Clinical Trials
- The Treatment of Hematologic Malignancies With Single or Double Umbilical Cord Blood Unit Transplantation Followed by Graft-Versus-Host Disease Prophylaxis With Tacrolimus and Mycophenolate Mofetil Start of enrollment: 2005 Sep 01
- Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil Start of enrollment: 2005 Sep 01
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant Start of enrollment: 2006 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsNoninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation.Johnathan Fraebel, Brian G Engelhardt, Tae Kon Kim> ;Transplantation and Cellular Therapy. 2023 Feb 1
- 7 citationsFeasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience.Bhagirathbhai Dholaria, Nasima Mehraban, Brittney Baer, Nancy Long, Reena V Jayani, Michael T Byrne, Adetola A Kassim, Brian G Engelhardt, Bipin N Savani, Olalekan O O...> ;British Journal of Haematology. 2022 Sep 1
- 1 citationsReduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation.Ameet Patel, Karina Wilkerson, Heidi Chen, Deva Sharma, Michael Byrne, Jennifer Green, Salyka Sengsayadeth, Bhagirathbhai Dholaria, Bipin Savani, Wichai Chinratanalab,...> ;Transplantation and Cellular Therapy. 2022 May 1
- Join now to see all
Press Mentions
Post-Transplant Diabetes May Be ReversibleFebruary 21st, 2020
Research Explores Link Between Stem Cell Transplant, DiabetesJanuary 17th, 2019
Professional Memberships
- Member
Hospital Affiliations
Vanderbilt University Medical CenterNashville, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
